This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ARIAD Pharmaceuticals Inc
ARIA : NASDAQ : Health Care
$5.15 -0.05 | -0.96%
Today's Range: 5.08 - 5.20
Avg. Daily Volume: 8,073,600
07/21/14 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
ARIA ARIAD PHARMACEUTICALS INC 5.20 971.35 n/m 50.88 633.02
NVAX NOVAVAX INC 4.22 988.78 n/m 24.54 15.40
RCPT RECEPTOS INC 35.95 956.59 n/m 4.50 202.62
EPZM EPIZYME INC 28.81 955.20 n/m 72.99 721.78
SRPT SAREPTA THERAPEUTICS INC 21.89 890.44 n/m 15.83 -48.25
INSY INSYS THERAPEUTICS INC 25.87 885.50 18.88 129.87 429.87
SGMO SANGAMO BIOSCIENCES INC 12.66 860.37 n/m 27.63 19.92
ARNA ARENA PHARMACEUTICALS INC 4.95 1087.27 n/m 85.84 209.08
LGND LIGAND PHARMACEUTICAL INC 51.32 1063.61 n/a 54.30 31.66
NBIX NEUROCRINE BIOSCIENCES INC 13.35 1012.77 n/m 2.19 -94.87
IMGN IMMUNOGEN INC 11.74 1007.45 n/m 57.98 67.31
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

ARIA Ind Avg S&P 500
n/m 53.95 19.62
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs